Dynamic contrast-enhanced MR imaging of the liver: current status and future directions.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Magnetic Resonance Imaging Clinics of North America

• Publication date

  2009-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.mric.2009.01.009PMID 19406362
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Optimal k‐space sampling for dynamic contrast‐enhanced MRI with an application to MR renography

  2009cited by this paper
• Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma.

  2008cited by this paper
• Characterization of hepatocellular carcinoma and colorectal liver metastasis by means of perfusion MRI

  2008cited by this paper
• Sorafenib in advanced hepatocellular carcinoma.

  2008cited by this paper
• Hepatic metastases: in vivo assessment of perfusion parameters at dynamic contrast-enhanced MR imaging with dual-input two-compartment tracer kinetics model.

  2008cited by this paper
• Chemotherapy for colorectal cancer liver metastases.

  2008cited by this paper
• Which study when? Is gadolinium-enhanced MR imaging safer than iodine-enhanced CT?

  2008cited by this paper
• Quantitative mapping of hepatic perfusion index using MR imaging: a potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120, a potent triple angiokinase inhibitor

  2008cited by this paper
• Update on nephrogenic systemic fibrosis.

  2008cited by this paper
• Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience.

  2008cited by this paper
• Quantitative determination of Gd‐DTPA concentration in T1‐weighted MR renography studies

  2007cited by this paper
• ACR guidance document for safe MR practices: 2007.

  2007cited by this paper
• Imaging of angiogenesis: clinical techniques and novel imaging methods.

  2007cited by this paper
• Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

  2007cited by this paper
• Transcytolemmal water exchange in pharmacokinetic analysis of dynamic contrast‐enhanced MRI data in squamous cell carcinoma of the head and neck

  2007cited by this paper
• Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging.

  2006cited by this paper
• Phase II study of sorafenib in patients with advanced hepatocellular carcinoma.

  2006cited by this paper
• Single breath‐hold T1 measurement using low flip angle TrueFISP

  2006cited by this paper
• Dynamic contrast-enhanced MR urography in the evaluation of pediatric hydronephrosis: Part 1, functional assessment.

  2005cited by this paper
• Perfusion imaging of the liver: current challenges and future goals.

  2005cited by this paper
• Comparison of the hepatic perfusion index measured with gadolinium-enhanced volumetric MRI in controls and in patients with colorectal cancer.

  2005cited by this paper
• Time-Resolved Contrast-Enhanced Three-Dimensional Magnetic Resonance Angiography of the Chest: Combination of Parallel Imaging With View Sharing (TREAT)

  2005cited by this paper
• Inflow correction of hepatic perfusion measurements using T1‐weighted, fast gradient‐echo, contrast‐enhanced MRI

  2004cited by this paper
• The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinoma

  2004cited by this paper
• Evaluation of Liver Fibrosis: A Concise Review

  2004cited by this paper
• Dynamic contrast-enhanced MRI analysis of perfusion changes in advanced hepatocellular carcinoma treated with an antiangiogenic agent: a preliminary study.

  2004cited by this paper
• Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension.

  2003cited by this paper
• Method for quantitation of dynamic MRI contrast agent uptake in colorectal liver metastases

  2003cited by this paper
• Capillarization of the sinusoids in liver fibrosis: Noninvasive assessment with contrast‐enhanced MRI in the rabbit

  2003cited by this paper
• Inflow effect in first‐pass cardiac and renal MRI

  2003cited by this paper
• Role of angiogenesis in the development and growth of liver metastasis

  2002cited by this paper
• Assessment of hepatic perfusion parameters with dynamic MRI

  2002cited by this paper
• Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.

  2002cited by this paper
• Breath‐hold perfusion and permeability mapping of hepatic malignancies using magnetic resonance imaging and a first‐pass leakage profile model

  2002cited by this paper
• Dynamic contrast‐enhanced MRI in clinical oncology: Current status and future directions

  2002cited by this paper
• Hepatic arterial buffer response in patients with advanced cirrhosis

  2002cited by this paper
• Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity.

  2001cited by this paper
• Detection of vascular endothelial growth factor and its receptor expression in human hepatocellular carcinoma biopsy specimens

  2000cited by this paper
• Impact of intrinsic blood flow regulation in cirrhosis: maintenance of hepatic arterial buffer response.

  2000cited by this paper
• Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model.

  2000cited by this paper
• Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis.

  2000cited by this paper
• Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium.

  1999cited by this paper
• Assessment of hepatic perfusion in pigs by pharmacokinetic analysis of dynamic MR images

  1999cited by this paper
• Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?

  1999cited by this paper
• Key factors in the acquisition of contrast kinetic data for oncology

  1999cited by this paper
• Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols

  1999cited by this paper
• Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging

  1997cited by this paper
• Time‐resolved contrast‐enhanced 3D MR angiography

  1996cited by this paper
• Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

  1996cited by this paper
• An immunohistochemical study of tumour vessels in metastatic liver cancers and the surrounding liver tissue

  1996cited by this paper
• MR measurements of mesenteric venous flow: prospective evaluation in healthy volunteers and patients with suspected chronic mesenteric ischemia.

  1995cited by this paper
• The hepatic extracellular matrix

  1993cited by this paper
• The hepatic extracellular matrix. II. Electron immunohistochemical studies in rats with CCl4-induced cirrhosis.

  1985cited by this paper

• Compressed Sensing‐Accelerated Free‐Breathing Liver MRI at 7 T

  2025cites this paper
• Multi-average high-acceleration modified volumetric interpolated breath-hold examination (VIBE) for free-breathing multiphase contrast-enhanced liver MRI: a comparative study with breath-hold VIBE

  2024cites this paper
• Complex extension of optical flow and its practical evaluation for undersampled dynamic MRI

  2024cites this paper
• Predicting overall survival in hepatocellular carcinoma patients via a combined MRI radiomics and pathomics signature

  2024cites this paper
• DCE‐MRI of the liver with sub‐second temporal resolution using GRASP‐Pro with navi‐stack‐of‐stars sampling

  2024cites this paper
• Multi-phasic magnetic resonance imaging of hemodynamic interchanges in hepatocarcinogenesis

  2023cites this paper
• Whole‐liver flip‐angle shimming at 7 T using parallel‐transmit kT‐point pulses and Fourier phase‐encoded DREAM B1+ mapping

  2023cites this paper
• Improved visualization of hepatic tumors in magnetic resonance–guided thermoablation using T1-inversion-recovery imaging with variable inversion time

  2023cites this paper
• Monitoring the hepatobiliary function using image techniques and labeled cholephilic compounds

  2023cites this paper
• Towards free breathing 3D ASL imaging of the human liver using prospective motion correction

  2022influential citation
• DCE-MRI evaluation of perfusional changes and ablation zone size following combination embolization and ablation therapy.

  2022cites this paper
• Imaging in translational cancer research

  2022cites this paper
• Validation study of perfusion parameter in hypervascular hepatocellular carcinoma and focal nodular hyperplasia using dynamic susceptibility magnetic resonance imaging with super-paramagnetic iron oxide: comparison with single level dynamic CT arteriography.

  2020cites this paper
• This is a repository copy of DCE-MRI for early prediction of response in hepatocellular carcinoma after TACE and sorafenib therapy: A pilot study . early prediction

  2020cites this paper
• Dynamic Contrast-Enhanced MRI: Basic Physics, Pulse Sequences, and Modeling

  2020cites this paper
• B0 and B1 inhomogeneities in the liver at 1.5 T and 3.0 T

  2020cites this paper
• Quantifying Perfusion Properties with DCE-MRI Using a Dictionary Matching Approach

  2020cites this paper
• Spatial-temporal perfusion patterns of the human liver assessed by pseudo-continuous arterial spin labeling MRI.

  2019cites this paper
• Quantitative Imaging in Pediatric Hepatobiliary Disease

  2019cites this paper
• Late Gadolinium Hyperintensity (LGH) of Colorectal Liver Metastases (CRLM) on Magnetic Resonance Imaging (MRI)

  2019cites this paper
• Living tissue intravoxel incoherent motion (IVIM) diffusion MR analysis without b=0 image: an example for liver fibrosis evaluation.

  2019cites this paper
• Liver assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging in primary biliary cholangitis patients

  2019cites this paper
• Application Value of Magnetic Resonance Perfusion Imaging in the Early Diagnosis of Rat Hepatic Fibrosis

  2019cites this paper
• Topics on quantitative liver magnetic resonance imaging.

  2019cites this paper
• Improved detection of a tumorous involvement of the mesorectal fascia and locoregional lymph nodes in locally advanced rectal cancer using DCE-MRI

  2018cites this paper
• DCE-MRI for Early Prediction of Response in Hepatocellular Carcinoma after TACE and Sorafenib Therapy: A Pilot Study

  2018cites this paper
• The role of dynamic contrast-enhanced MRI analysis of perfusion changes in hepatocellular carcinoma

  2018cites this paper
• Gd-EOB-DTPA magnetic resonance imaging in hepatocellular carcinoma patients after transcatheter arterial chemoembolization

  2018cites this paper
• Hepatic function imaging using dynamic Gd‐EOB‐DTPA enhanced MRI and pharmacokinetic modeling

  2017cites this paper
• Dynamic Contrast-Enhanced Magnetic Resonance Imaging With Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid for Quantitative Assessment of Vascular Effects on Hepatocellular-Carcinoma Lesions Treated by Transarterial Chemoembolization or Radiofrequency Ablation

  2016cites this paper
• Comparison of CAIPIRINHA-VIBE, Radial-VIBE, and conventional VIBE sequences for dynamic contrast-enhanced (DCE) MRI: A validation study using a DCE-MRI phantom.

  2016cites this paper
• Quantitative Assessment of Liver Function Using Gadoxetate-Enhanced Magnetic Resonance Imaging

  2016cites this paper
• The clinical value of dynamic contrast-enhanced MRI in differential diagnosis of malignant and benign ovarian lesions

  2015cites this paper
• Diagnostic Value of Semiquantitative Analysis of Dynamic Susceptibility Contrast Magnetic Resonance Imaging with GD-EOB-DTPA in Focal Liver Lesions Characterization: A Feasibility Study

  2015cites this paper
• Analysis of current MRI capabilities in diagnosis of the focal liver lesions

  2015cites this paper
• Assessment of Body Composition

  2015cites this paper
• Assessment of liver function and liver fibrosis with dynamic Gd-EOB-DTPA-enhanced MRI.

  2015cites this paper
• The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA “uptake” on the hepatobiliary phase of MR imaging

  2015cites this paper
• DCE‐MRI of the liver: Effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibility

  2014cites this paper
• Functional MR imaging of the abdomen.

  2014cites this paper
• Assessment of angiogenesis of hepatocellular carcinoma using dynamic contrast enhanced MR and histopathologic correlation in an experimental rat model.

  2014cites this paper
• Perfusion imaging in liver MRI.

  2014cites this paper
• Evaluation of Neuroendocrine Liver Metastases: A Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography

  2014cites this paper
• Role of Functional MRI in the Management of Liver Metastases

  2014cites this paper
• 3934 HEPATOCELLULAR ADENOMAS : CURRENT FINDINGS IN IMAGES WHICH ALLOW THEIR CHARACTERIZATION AND MANAGEMENT ADENOMAS

  2014cites this paper
• MRI with Gadoxetate Disodium for Colorectal Liver Metastasis: Is It the New “Imaging Modality of Choice”?

  2014cites this paper
• Vascular and hepatic enhancements at MR imaging: comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects.

  2014cites this paper
• MR imaging of scrotum.

  2014cites this paper
• Diagnostic accuracy of dynamic gadoxetic‐acid–enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms

  2014cites this paper
• Liver dynamic contrast‐enhanced MRI for staging liver fibrosis in a piglet model

  2014cites this paper
• DCE-MRI of the Liver: Reconstruction of the Arterial Input Function Using a Low Dose Pre-Bolus Contrast Injection

  2014cites this paper
• Functional imaging of the liver.

  2013cites this paper
• The Role of Imaging in Hepatocellular Carcinoma: The Present and Future

  2013cites this paper
• Gd-EOB-DTPA-Enhanced MRI for Detection of Liver Metastases from Colorectal Cancer: A Surgeon's Perspective!

  2013cites this paper
• Assessing liver function using dynamic Gd‐EOB‐DTPA‐enhanced MRI with a standard 5‐phase imaging protocol

  2013cites this paper
• Spleen Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a New Method for Staging Liver Fibrosis in a Piglet Model

  2013cites this paper
• Parenchymal signal intensity in 3-T body MRI of dogs with hematopoietic neoplasia.

  2013cites this paper
• Diagnosis of hepatocellular carcinoma: newer radiological tools.

  2012cites this paper
• Practical Body MRI: Protocols, Applications and Image Interpretation

  2012cites this paper
• Contrast agents as a biological marker in magnetic resonance imaging of the liver: conventional and new approaches

  2012influential citation
• Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging.

  2012cites this paper
• Hepatobiliary MR imaging with gadolinium‐based contrast agents

  2012cites this paper
• Tools to Enhance the Contrast in MR Images: From Lanthanide Complexes and Iron Oxide Particles to MEMRI

  2012cites this paper
• Measuring liver function with dynamic gadoxetic acid enhanced MRI at low temporal resolution: a validation study

  2012cites this paper
• Detection of small intrahepatic metastases of hepatocellular carcinomas using diffusion-weighted imaging: comparison with conventional dynamic MRI.

  2011cites this paper
• Magnetic resonance imaging of hepatocellular carcinoma: a pictorial review of novel insights into pathophysiological features revealed by magnetic resonance imaging

  2010cites this paper